Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Vandendijck

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Plos One|June 6, 2022
Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitalsMarijke Proesmans, Annabel Rector, Els Keyaerts, et al.
Journal of Patient-Reported Outcomes|June 1, 2023
Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scoresRichard H Osborne, Lauren M Nelson, Sheri Fehnel, et al.
The New England Journal of Medicine|November 26, 2025
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection ModelAnna P Durbin, Liesbeth Van Wesenbeeck, Kristen K Pierce, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Plos One|June 6, 2022
Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitalsMarijke Proesmans, Annabel Rector, Els Keyaerts, et al.
Journal of Patient-Reported Outcomes|June 1, 2023
Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scoresRichard H Osborne, Lauren M Nelson, Sheri Fehnel, et al.
The New England Journal of Medicine|November 26, 2025
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection ModelAnna P Durbin, Liesbeth Van Wesenbeeck, Kristen K Pierce, et al.
Pageof 2